Nu-Greens Profile Liquid
Natural health product licensed in Canada
- Licence holder
- Lifeagen Biosciences of Florida, Inc. dba Nu-Life North America
- NPN or DIN-HM
- 80109396
- Status
- Active licence
- Licence date
- 19 April 2021
- Revision date
- Not provided
- Form
- Liquide
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
- Conditions légales
Contains tea (Camellia sinensis). Green tea extracts must provide less than 800 mg of epigallocatechin-3-gallate per daily portion, with mandatory warnings.
annexe III, partie B (règlement (UE) 2022/2340). Regulation (EC) No 1925/2006, latest consolidated version, retrieved 21 October 2026.
- Conditions légales
Brassica oleracea L.: L'étiquetage doit comporter un avertissement recommandant aux personnes ayant une hypothyroïdie ou un traitement de la thyroïde de consulter leur médecin.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Aloe vera (L.) Burm. f.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux enfants de moins de 12 ans, aux femmes enceintes et allaitantes et une mention déconseillant l'usage prolongé
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Camellia sinensis (L.) Kuntze: Seules sont admises la poudre issue du broyage des feuilles et les préparations obtenues à partir des solvants suivants : l'eau, l'alcool à 25 % (v/v), ainsi que les solvants autorisés pour la décaféination ou la suppression des matières irritantes et amères. Les recommandations d'emploi ne doivent pas conduire à une ingestion quotidienne d'EGCG supérieure à 300 mg. L'étiquetage doit comporter des avertissements déconseillant leur prise en dehors des repas, ainsi que leur consommation par les enfants, les adolescents, les femmes enceintes ou allaitantes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Brassica oleracea var. botrytis Source : Plante entière | 29.2 mg | Not calculated |
| Folate Source : Acide folique | 120 mcg | Not calculated |
| Spinacia oleracea Source : Feuille | 102.2 mg | Not calculated |
| Potassium Source : Citrate de potassium | 4 mg | Not calculated |
| Brassica oleracea var. capitata Source : Feuille | 14.6 mg | Not calculated |
| Allium porrum Source : Plante entière | 2.92 mg | Not calculated |
| Aloe vera Source : Feuille Extract : Matériel brut sec Extraction ratio : 200:1 Dry plant equivalent : 3,000 mg | 15 mg | Not calculated |
| Raphanus sativus Source : Racine | 8.76 mg | Not calculated |
| Camellia sinensis Source : Feuille Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 58.4 mg | 14.6 mg | Not calculated |
| Stérols végétaux libres Source : Glycine max - Graine Potency : 90 % Combined beta-Sitosterol, Campesterol and Stigmasterol | 400 mg | Not calculated |
| Beta vulgaris Source : Feuille | 20.44 mg | Not calculated |
| Apium graveolens Source : Graine | 14.6 mg | Not calculated |
| Trisodium (2S-trans)-(18-carboxy-20-(carboxymethyl)-13-éthyl-12-formyl-2,3-dihydro-3,7,17-triméthyl-8-vinyl-21H,23H-porphine-2-propionato(5-)-N21,N22,N23,N24)cuprate(3-) Source : Sodium copper chlorophyllin | 16 mg | Not calculated |
| Petroselinum crispum Source : Feuille Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 292 mg | 73 mg | Not calculated |
Non-medicinal ingredients
Acide citrique, Extrait de feuilles de stévia, Benzoate de sodium, Gomme de xanthane, Eau purifiée, Acide L-malique, Sorbate de potassium, Sucre de betterave, Saveur, Saveur de baies
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 30 mL | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
A factor in the maintenance of good health. Contributes to maintaining general health. For maintaining general health. Helps in energy metabolism and in tissue formation. Helps in energy metabolism in the body. Helps in the normal function of the immune system. Helps to form red blood cells. Helps to maintain healthy metabolism. Helps to maintain the body's ability to metabolize nutrients. Maintains good health. Source of antioxidant(s)/Provides antioxidant(s). Source of antioxidant(s)/Provides antioxidant(s) that help(s) fight/protect (cell) against/reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals. Source of vitamin(s)/mineral(s)/vitamin(s) and mineral(s), a factor/factors in normal growth and development. Source of vitamin(s)/mineral(s)/vitamin(s) and mineral(s), a factor/factors in the maintenance of good health. Source of vitamin(s)/mineral(s)/vitamin(s) and mineral(s) to support biological functions which play a key role in the maintenance of good health. Supports good health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80109396
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.